TwinKnowledge | $3,700,000 | (Apr 3, 2025)
Further AI | $5,000,000 | (Apr 3, 2025)
Vivere | $7,500,000 | (Apr 3, 2025)
Certified by Founder
Lodge
Vaxinano
start up
France
- Loos, Hauts-de-France
- 30/10/2024
- Unknown
- $6,503,959
Vaxinano is a clinical-stage biotechnology company, developing a new generation of nasally administered vaccines that are more efficient and faster to deploy to combat infectious diseases and new pandemics.
The vaccine is based on STELLAR-NP nanoparticles that confer highly stable, adjuvant-free solution for an effective and long-lasting response tot protect against the most difficult pathogens, such as parasites, viruses or bacteria...
- Industry Biotechnology Research
- Website https://www.vaxinano.com/
- LinkedIn https://www.linkedin.com/company/vaxinano/
SchoolAI | $25,000,000 | (Apr 3, 2025)
Ropes | $3,100,000 | (Apr 3, 2025)
experial | $2,198,930 | (Apr 3, 2025)
Cambrian Network | $5,900,000 | (Apr 3, 2025)
Actively AI | $22,500,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
Sturdy | $6,000,000 | (Apr 2, 2025)
Tomorro | $26,995,875 | (Apr 2, 2025)
voize | $9,000,000 | (Apr 2, 2025)